CorePAM: a 24-gene PAM50-derived expression score with cross-platform external validation for breast cancer prognosis.
Saved in:
| Title: | CorePAM: a 24-gene PAM50-derived expression score with cross-platform external validation for breast cancer prognosis. |
|---|---|
| Authors: | de Negreiros Botan R; School of Medicine, University of Brasília, Brasília, 70910-900, DF, Brazil. oncologista@gmail.com.; Medical Sciences Postgraduate Program, School of Medicine, University of Brasília, Brasília, Brazil. oncologista@gmail.com., de Sousa JB; School of Medicine, University of Brasília, Brasília, 70910-900, DF, Brazil.; Medical Sciences Postgraduate Program, School of Medicine, University of Brasília, Brasília, Brazil.; Department of Colorectal Surgery, Hospital Universitário de Brasília, Brasília, Brazil. |
| Source: | Breast cancer research : BCR [Breast Cancer Res] 2026 May 21; Vol. 28 (1). Date of Electronic Publication: 2026 May 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1465-542X |
|---|---|
| DOI: | 10.1186/s13058-026-02298-5 |
